According to John Miller, executive director, MidAtlantic Business Group on Health, The National Business Coalition on Health (NBCH) is an organization that seeks to drive conversations about prescription drug benefit management (PBM) to value.
According to John Miller, executive director, MidAtlantic Business Group on Health, The National Business Coalition on Health (NBCH) is an organization that seeks to drive conversations about prescription drug benefit management (PBM) to value. Utilizing an evidence-based, comprehensive assessment called ValuePort, NBCH helps employers consider the value PBMs provide in quality (rather than cost alone).
The members and coalitions in NBCH aim to develop programs that underline their 4 pillars of value-based purchasing. Those four pillars include: “standardizing performance measurement, reporting performance measurement results publicly, reforming the health care delivery payment system, and engaging consumers in informed decision making.”
NBCH’s assessment, a subset of their other program eValue8, promotes quality and transparency by incorporating services such as URAC and NCQA accreditations into its measurements. eValue8 is NBCH’s “flagship” vendor management tool that is used by employers to measure vendor performance. Valueport builds on eValue8’s offerings by including performance comparisons and rankings, as well as raising plan sponsor expectations. It is hoped that these quality measures will help providers and vendors to better understand data and to implement strategies that will improve health outcomes.
Miller suggests that their assessment focuses on population health, cultural competencies such as ethnicity and geography, and patient engagement. While not a consumer-based service, Miller says it’s important for stakeholders to get involved with “wise decision making” as close to the consumer as possible. This is especially true for management of conditions such as diabetes and obesity.
Coalitions who participated in a pilot program of ValuePort found that there were opportunities for more meaningful engagement with employers, access to training and skill development of useful data analysis, and an ability to observe other coalitions’ best practices and approaches to value-based purchasing.
The ValuePort assessment will be used by the NBCH’s 60 coalitions and will reach approximately 7,000 employers. Miller suggests that other PBMs can benefit in collaborating with employers.
The Pivotal Role of Payers in Improving Health Equity, Maternal Health Care in the US
March 26th 2024A presentation at the Greater Philadelphia Business Coalition on Health's 2024 Women’s Health Summit discussed how payers, including employers and public entities, can strategically influence health care purchasing to prioritize maternal health and equity.
Read More
The Importance of Examining and Preventing Atrial Fibrillation
August 29th 2023At this year’s American Society for Preventive Cardiology Congress on CVD Prevention, Emelia J. Benjamin, MD, ScM, delivered the Honorary Fellow Award Lecture, “The Imperative to Focus on the Prevention of Atrial Fibrillation,” as the recipient of this year’s Honorary Fellow of the American Society for Preventive Cardiology award.
Listen
Dupilumab Considered Safe, Effective Treatment for Adolescent, Adult Patients With AD
March 20th 2024These posters both used the GLOBOSTAD study, which demonstrated through patient and physician assessments that dupilumab is a safe and effective treatment for adolescent and adult patients with atopic dermatitis (AD).
Read More
Promoting Equity in Public Health: Policy, Investment, and Community Engagement Solutions
June 28th 2022On this episode of Managed Care Cast, we speak with Georges C. Benjamin, MD, executive director of the American Public Health Association, on the core takeaways of his keynote session at AHIP 2022 on public health policy and other solutions to promote equitable health and well-being.
Listen
Racial Variations in Cardiovascular Outcomes Found in Hidradenitis Suppurativa Study
March 19th 2024Based on the findings, investigators acknowledged the critical need to consider racial differences when assessing patients with hidradenitis suppurativa. Health care providers should be vigilant in addressing cardiovascular risk factors in this population, recognizing and addressing racial disparities that may impact disease management.
Read More